Literature DB >> 11427584

Mycolic acid index susceptibility method for Mycobacterium tuberculosis.

J M Viader-Salvadó1, E Garza-González, R Valdez-Leal, M A del Bosque-Moncayo, R Tijerina-Menchaca, M Guerrero-Olazarán.   

Abstract

A rapid drug susceptibility test to measure the susceptibility of Mycobacterium tuberculosis to isoniazid (INH) and rifampin (RIF) using clinical isolates and a newly defined mycolic acid index (MAI) was evaluated. A total of 200 clinical isolates of M. tuberculosis were tested for susceptibility or resistance to INH and RIF by the MAI susceptibility and indirect-proportion methods. Overall, there was agreement between the two methods for 398 (99.5%) of the 400 total tests. Specifically, the sensitivity of the MAI susceptibility method for INH and RIF was 97.6 and 100%, respectively. The specificity and positive predictive value were 100% for both drugs, and the negative predictive value for INH and RIF was 98.3 and 100%, respectively. In conclusion, the MAI susceptibility method described here can be used for rapid drug susceptibility testing of M. tuberculosis clinical isolates within 5 days after clinical isolates are incubated in the presence or absence of an antituberculosis drug.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427584      PMCID: PMC88200          DOI: 10.1128/JCM.39.7.2642-2645.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Drug Susceptibility of Mycobacterium tuberculosisThrough the Mycolic Acid Index.

Authors:  J M Viader-Salvadó; M Guerrero-Olazarán; E Garza-González; R Tijerina-Menchaca
Journal:  Methods Mol Med       Date:  2001

3.  Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis.

Authors:  E Garza-González; M Guerrero-Olazarán; R Tijerina-Menchaca; J M Viader-Salvadó
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  Identification of mycobacteria by mycolic acid pattern.

Authors:  E Garza-Gonzalez; M Guerrero-Olazaran; R Tijerina-Menchaca; J M Viader-Salvado
Journal:  Arch Med Res       Date:  1998       Impact factor: 2.235

5.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

6.  Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models.

Authors:  K C Jost; D F Dunbar; S S Barth; V L Headley; L B Elliott
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

  6 in total
  3 in total

1.  Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis.

Authors:  Nicole Parrish; Gerard Osterhout; Kim Dionne; Amy Sweeney; Nicole Kwiatkowski; Karen Carroll; Kenneth C Jost; James Dick
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

2.  The Assessment of Viability of M. Tuberculosis after Exposure to CPC Using Different Methods.

Authors:  Gomathi Sekar; R Lakshmi; N Selvakumar
Journal:  Int J Bacteriol       Date:  2014-01-28

3.  Antimycobacterial susceptibility testing methods for natural products research.

Authors:  Juan Gabriel Bueno Sánchez; Vladimir V Kouznetsov
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.